Clinical Trial Update: Gene Mapping for Quantitative Traits

View source ↗

Summary

The NHLBI-sponsored clinical trial on gene mapping for quantitative traits related to cardiovascular disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Heart Disease

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases, Heart Diseases | Status: COMPLETED